One assignee leads the ranked list with 44 records, noticeably ahead of the fifth-place holder at 25 and tenth place at 14. That said, the top 5 assignees combined account for only 20.3% of the full 785-record set, so leadership at the top does not translate into control of the whole field. Most of the corpus sits with a long tail of smaller filers and single-patent entrants, which is common in fields that blend surgical instrumentation with general power hardware.

Filing peaked in 2017 at 55 records and has settled into a lower, roughly stable band since. Comparing 2021 (36 filings) to 2024 (35 filings), the most recent span that can be treated as complete, shows only a -3% change — essentially flat rather than a clear rise or fall. The very low counts shown for 2025 and 2026 are an artefact of the roughly 18-month lag between filing and publication, not evidence of a slowdown, so they should be read with that caveat rather than taken at face value.

The search terms used to build this dataset combine robotic-instrument energy claims with general energy-device language, which pulls in classification codes shared with wind, marine and industrial power hardware. F03B (hydraulic machines & engines) covers 22.8% of the 785 records and H02K (electric motors & generators) covers 11.7%, both ahead of the surgery-specific A61B class at 13.4%. This reflects how patent classification works at the mechanism level — a rotary or hydraulic energy-conversion claim can read the same whether it sits inside a surgical handpiece or an offshore turbine — rather than any surgical-specific finding.

Based on the classification spread and the sub-areas named in the search claims, force feedback in energized wristed instruments, sterilization-compatible cable routing, reprocessing cycles for energy-delivery tips and instrument-life monitoring for RF or ultrasonic tools all show thinner direct coverage than the core energy-generation and delivery classes. These are not empty, but they sit adjacent to the densest claim territory rather than inside it, which typically leaves more room for a narrowly drafted independent claim. Any filing decision here should still be checked against the leading assignee's specific claim scope before relying on a class-level gap.

The United States is the dominant receiving office with 263 filings, more than double the next tier. China (88), WIPO under the PCT (87) and the European Patent Office (85) form a closely grouped second tier, with the United Kingdom (53) and Australia (50) further behind. For a company assessing freedom-to-operate risk, this pattern makes the US the first jurisdiction to clear, with PCT and EPO filings worth checking next given their near-equal volume to China.